Loading…
Loading…
BYAH does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for BYAH and 80,000+ other tickers.
See exactly how BYAH's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for BYAH and 80,000+ other tickers.
This enterprise functions as an investment holding company, with its core business centered on crafting and distributing skincare solutions. Operating under the "Park Ha" brand, these products are sold across the People's Republic of China. The company executes these activities through its affiliated subsidiaries, which manage both direct product sales and the provision of franchise services.
NEW YORK, Aug. 26, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.
SAN DIEGO--(BUSINESS WIRE)---- $BYAH #Health--Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) securities between December 27, 2024 and July 8, 2025 (the "Class Period"). The Company traded under ticker symbol "PPH" until October 28, 2025. Park Ha develops and sells skincare and cosmetics products under the “Park Ha” brand and operates franchise beauty stores.
NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) and certain of its officers.
BYAH reported just 39 franchisees and $551,970 in franchise fee revenue, yet the lawsuit contends BYAH carried a $1 billion market capitalization before shares collapsed 93% in a single session. NEW YORK, Aug. 26, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Park Ha Biological Technology Co., Ltd.
New York, New York--(Newsfile Corp. - August 25, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.